Fundraising FoxEssex Woodlands Healthcare Partners — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
MIMEDX develops advanced wound care and surgical products derived from placental tissue, serving healthcare professionals and patients.
BiotechHealthtechMedical DevicesMarietta, US
William C. Taylor(Executive Officer, Director)Parker H. Petit(Executive Officer, Director)Alexandra O. Haden(Executive Officer)Michael J. Senken(Executive Officer)Joseph H. Capper(Chief Executive Officer)Doug Rice(Chief Financial Officer)in
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.
AI & Machine LearningBiotechHealthtechDurham, US
John A. Ryals(Executive Officer, Director)inGerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)inJohn Ryals, Ph.D(Founder)Rohan (Ro) F. Hastie, Ph.D.(President & Chief Executive Officer)
BoardJohn Oxaal(Director)
Co-investorsCamden PartnersHavencrest Capital ManagementRevelation PartnersSyngenta Group Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.